COLO B Coloplast A/S Class B

Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 2025

Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 2025

The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)

Ellehammersvej 20, 2770 Kastrup

from 10.30 - 17.00 CEST

(Central European Summer Time)

Coloplast invites institutional investors, equity analysts and media to attend our 2025 Capital Markets Day.

The event will be held in person at Clarion Hotel in Copenhagen, Denmark, with the option to join virtually for the plenary session.

The purpose of the event is to give institutional investors and financial analysts an introduction to the new 5-year strategy for the company, as well as to provide the opportunity to meet with the broader Management team.

The day will start with a plenary session, covering the introduction of the new Group strategy, a financial update, and the strategy for the Chronic Care businesses. In the afternoon, participants will be split into groups and rotate between four Q&A breakout sessions. Participation in the breakout sessions will be in-person only (with a replay of the presentations available after the event).

The formal program will end at 17.00, followed by an opportunity to meet the Coloplast management team in an informal setting.

Agenda in CEST

10.00 - 10.30  Registration

10.30 - 12.30  Plenary session: Group strategy and financials, strategy for Chronic Care and Voice and Respiratory Care

12.30 - 13.00  Lunch break

13.00 - 17.00  Q&A breakout sessions (incl. breaks)

17.00 - 18.30  Social activity (on premise)

Coloplast representatives

Plenary session:  

  Lars Rasmussen, Interim President and CEO

  Anders Lonning-Skovgaard, Executive Vice President, CFO

  Nicolai Buhl, Executive Vice President, Chronic Care

  Caroline Vagner Rosenstand, Executive Vice President, Voice & Respiratory Care

Breakout sessions:  

  Chronic Care deep dive:

  Mike DelVacchio, Senior Vice President, North America

  Thomas Bruhn, Senior Vice President, Emerging Markets

  Advanced Wound Care:

  Fertram Sigurjonsson, Founder and President, Kerecis

  Bernd Greiner, Senior Vice President, Adv. Wound Dressings

  Interventional Urology:

  Thomas NP Johns Jr, Executive Vice President, Interventional Urology

  Global Operations and People & Culture:

  Allan Rasmussen, Executive Vice President, Global Operations

  Dorthe Rønnau, Executive Vice President, People & Culture

In-person participation

If you wish to join us in-person and attend the plenary session and the Q&A breakout sessions, please register by sending an email to stating your full name, company, contact phone number and itinerary (if relevant).

Kindly register before Friday, 15 August 2025.

Virtual participation

Virtual participation will be possible for the plenary session.

A link for the webcast of the plenary sessions will be available on our website closer to the date.

For more information,

please contact:

Aleksandra Dimovska, Vice President

Direct tel.:

E-mail:  

Simone Dyrby Helvind, Sr. Manager  

Direct tel.:

E-mail:  

Julie Sommer Müggler, Coordinator   

Direct tel.:

Email:  

Attachment



EN
03/06/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

 PRESS RELEASE

Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 Sep...

Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 2025 The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)Ellehammersvej 20, 2770 Kastrupfrom 10.30 - 17.00 CEST(Central European Summer Time) Coloplast invites institutional investors, equity analysts and media to attend our 2025 Capital Markets Day.The event will be held in person at Clarion Hotel in Copenhagen, Denmark, with the option to join virtually for the plenary session.The purpose of the event is to give institutional investors and financial analysts an introductio...

Coloplast AS: 1 director

A director at Coloplast AS bought 18,450 shares at 650.500DKK and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

 PRESS RELEASE

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående p...

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier Se venligst vedlagte pdf.   Vedhæftet fil

 PRESS RELEASE

Coloplast A/S - Trading in Coloplast shares by board members, executiv...

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Please see enclosed pdf.   Attachment

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen

ResearchPool Subscriptions

Get the most out of your insights

Get in touch